Insider Transactions in Q1 2021 at Finch Therapeutics Group, Inc. (FNCH)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2021
|
Crestovo Investor LLC Director |
BUY
Open market or private purchase
|
Direct |
735,294
+5.5%
|
$12,499,998
$17.0 P/Share
|
|
Mar 23
2021
|
Crestovo Investor LLC Director |
BUY
Conversion of derivative security
|
Direct |
11,906,147
+50.0%
|
-
|
|
Mar 23
2021
|
Domenic J Ferrante Director |
BUY
Open market or private purchase
|
Indirect |
102,941
+13.93%
|
$1,749,997
$17.0 P/Share
|
|
Mar 23
2021
|
Domenic J Ferrante Director |
BUY
Conversion of derivative security
|
Indirect |
533,254
+34.98%
|
-
|
|
Mar 23
2021
|
Nicholas Haft Director |
BUY
Open market or private purchase
|
Indirect |
882,351
+50.0%
|
$14,999,967
$17.0 P/Share
|
|
Mar 23
2021
|
Nicholas Haft Director |
BUY
Conversion of derivative security
|
Indirect |
3,110,706
+45.06%
|
-
|
|
Mar 23
2021
|
Jeffery A Smisek |
BUY
Open market or private purchase
|
Indirect |
88,235
+4.95%
|
$1,499,995
$17.0 P/Share
|
|
Mar 23
2021
|
Jeffery A Smisek |
BUY
Conversion of derivative security
|
Indirect |
1,606,306
+23.69%
|
-
|